It has been widely described that Nrf2 overexpression in different tumor types contributes to pro-oncogenic processes and chemoresistance [54] by promoting the transcription of antioxidant (NQO1), detoxifying (SULT1A1), and anti-apoptotic (BCL-2) enzymes with ARE element [55]. The gene discussed is BCL2; the disease is neoplasm.